Actos Bladder Cancer Lawsuits
While the benefits of taking Actos (pioglitazone) are well worth it for many people, studies have found that the drug may be responsible for causing bladder cancer, which normally presents itself in the form of tumors on the bladder. The U.S. Food and Drug Administration (FDA) has stated that there is sufficient evidence to necessitate further studies into this matter. Both the FDA and the company that makes Actos, Takeda Pharmaceuticals, are in the midst of performing their own research concerning Actos and cancer.
Actos has already been pulled from the market in France and Germany, based on results from an international study that showed Actos is linked to an increased risk for bladder cancer. In the U.S., the drug remains on the market despite evidence that it may increase the risk for bladder cancer by 40 percent after 12 months of use.
If you're concerned about Actos and its cancer risk, the first step you should take is to speak to your health care provider. Your doctor will be able to answer any questions and address any concerns that you might have relating to Actos. You might be able to stop using the medication and switch to a safer form of treatment, if you and your doctor believe that is best. If you are experiencing symptoms, your doctor can determine if you're suffering serious side effects as a result of your Actos use.
Help for Bladder Cancer Patients
If you or a family member has been diagnosed with bladder cancer and you have a history of Actos use, you may be eligible for financial compensation. To find out if you qualify to file a lawsuit for your injuries, please contact us today. Our Actos lawyers are currently investigating potential lawsuits on behalf of bladder cancer patients and their families.